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Abstract 
A manufacturer utilizes methylene chloride (CH2Cl2) (CAS 75-09-2), also known as 
dichloromethane, to manufacture active pharmaceutical ingredients. Methylene chloride is 
specifically regulated by the Occupational Safety and Health Administration (OSHA) under 29 
Code of Federal Regulation (CFR) 1910.1052. Evaluation and documentation of employee 
exposure to methylene chloride is required to comply with OSHA regulations. In addition to 
OSHA compliance, it is also important to evaluate employee exposure levels to determine if 
respiratory protection, regulation of the work area, and medical monitoring are necessary.  
This industrial hygiene report describes an investigation into the risks of exposure to methylene 
chloride. This report includes evaluation of employee exposure to methylene chloride during the 
manufacture of active pharmaceutical ingredients. During the manufacture of active 
pharmaceutical ingredients, employees transfer methylene chloride from small containers to a 
large reactor. After the desired reaction has taken place and allowed to separate, different layers 
of the solution which contains methylene chloride are drained from the reactor into small 
containers. Employees have the potential for exposure to methylene chloride during the transfer 
and collection processes.  
The results of the occupational exposure sampling indicate employees are exposed to levels of 
methylene chloride above the permissible exposure limit (PEL) and the action limit (AL). The 
regulatory standard requires medical monitoring when employees are exposure above the AL. 
Regulation of the work area and respiratory protection is required at the PEL.  
Recommendations to reduce exposure include identifying a substitute solvent that is less 
hazardous. To control exposure through an engineering control, an evaluation of the current 
localized ventilation system would be valuable in determining existing capabilities for reducing 
exposure to methylene chloride vapors. If this is not possible with the current ventilation system, 
other ventilation options could be explored. An engineering control to reduce exposure during 
methylene chloride transfer from pails to the reactor may be achieved by applying nitrogen 
pressure to the bucket to force methylene chloride from one container to the reactor vessel from a 
remote location. Reduction of exposure during transfer from the bottom of the reactor to 
collection pails may be achieved by attaching a hose to the bottom of the reactor and channeling 
discharge into a closed top container. The implementation of either of these controls would 
necessitate additional exposure monitoring to evaluate the effectiveness. 
Keywords: 
Methylene chloride, dichloromethane, exposure monitoring, active pharmaceutical ingredient 
manufacturing 
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Glossary of Terms  
 
Term Definition 
29 CFR 1910.1052 29 Code of Federal Regulation (CFR) 1910.1052 is known as the 
methylene chloride standard 
  
AIHA American Industrial Hygiene Association 
  
AL Action Level is established by OSHA as the 8-hour time-weighted 
average exposure level at which exposure regulatory requirements 
are applicable 
  
ATSDR Agency for Toxic Substances and Disease Registry 
  
PEL Permissible Exposure Limit established by OSHA to protect workers 
from adverse exposure effects based on an 8-hour time-weighted 
average 
  
NIOSH National Institute of Occupational Safety and Health 
  
OSHA Occupational Safety and Health Administration 
  
TWA Time-weighted average; the average exposure over a given period of 
time  
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1. Introduction  
A manufacturer utilizes methylene chloride (CH2Cl2) (CAS 75-09-2), also known as 
dichloromethane, to manufacture active pharmaceutical ingredients. Methylene chloride is 
specifically regulated by the Occupational Safety and Health Administration (OSHA) under 29 
Code of Federal Regulation (CFR) 1910.1052. To comply with this regulation, it is necessary to 
conduct an initial exposure determination to determine employees’ exposure levels. The 
manufacturer indicated exposure monitoring had been conducted and exposure limits were below 
the action level (AL) and permissible exposure limit (PEL). However, documentation pertaining 
to the exposure monitoring, including the calculated exposure levels, was unavailable.  
Evaluation and documentation of employee exposures to methylene chloride is required 
to comply with the OSHA methylene chloride standard. It is also important to evaluate employee 
exposure levels to determine if respiratory protection, regulation of the work area, and medical 
monitoring are necessary.  
This industrial hygiene report will include a review of the risks of exposure to methylene 
chloride. This project will also include evaluation of employee exposure to methylene chloride 
during the manufacture of active pharmaceutical ingredients. The results of the exposure 
evaluation provided in this report were used to recommend appropriate actions (e.g., regulatory 
compliance, engineering controls, additional monitoring). 
1.1. Process Description 
The process of manufacturing active pharmaceutical ingredients is a multi-step process. 
Chemicals used in the manufacturing process are transferred from the suppliers’ containers (e.g., 
drums, 4-liter bottles, pails) to properly labeled 5-gallon pails which are then weighed and staged 
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in the work area (see Figure 1). These transfer activities are performed the day prior to initiating 
manufacturing activities and were not included in this evaluation.  
Figure 1: Pails containing chemicals staged in the work area. 
 
 
As the manufacturing process begins, the first step includes charging the reactor (i.e., 
pouring materials into the reactor) with a proprietary compound, methylene chloride and 
additional chemicals to facilitate a reaction. To accomplish this step, Employee 1 climbs steps to 
an elevated platform that is staged near the reactor (see Figure 2). Employee 2 carries the pails to 
the elevated platform. Employee 1 then opens the containers and pours the contents into the 
reactor. At this time, localized ventilation (i.e., a snorkel, trunk exhaust duct or extraction arm) is 
positioned near the opening of the reactor (see Figure 3). The localized ventilation is provided by 
a Plymovent extraction arm which is intended to capture chemical vapors. The employees wear 
supplied-air, full-faced respirators, laboratory coats and chemical-compatible gloves. This 
portion of the manufacturing process occurs intermittently over an approximate four hour period 
as dictated by the desired reaction and quenching of the reaction. 
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Figure 2: View of the elevated platform with reactor in the background 
 
 
Figure 3: Movable ventilation duct. 
 
 
After allowing time for the phases of the solution to separate, the aqueous layer of the 
material is then released from the reactor through a drain at the bottom of the reactor into 
appropriately labeled 5-gallon pails (see Figure 4). After additional stirring, the material is 
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allowed time to separate again. The methylene chloride layer (i.e., the halogenated waste layer) 
is then collected in to appropriately labeled 5-gallon pails. At this time, localized ventilation (i.e., 
extraction arm) is positioned near the discharge location at the bottom of the reactor. The 
employees wear supplied-air, full-faced respirators, laboratory coats and chemical-compatible 
gloves. This activity occurs intermittently over an approximate four hour period.  
Figure 4: Bucket staged below reactor to capture separated layers. 
 
 
The remaining material is then filtered as it is removed. The liquid potion is captured in 
pails while the solids are captured on a filtering cloth. The employees wear supplied-air, full-
faced respirators, laboratory coats and chemical-compatible gloves. This typically occurs the 
next day over an approximate 15 minute period.   
2. Hypotheses 
As the methylene chloride exposure level was not established, it was unknown if 
respiratory protection, regulation of the work area, and medical monitoring are necessary to meet 
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the requirements of 1910.1052. This evaluation is important to determine regulatory compliance 
responsibilities.  
Information about the toxicology of methylene chloride and background information as 
to the risks of methylene chloride exposure are provided in Section 4 which emphasizes the 
importance of evaluating methylene chloride exposure levels.  
This research was designed and implemented with the intention of answering the 
following question: “what is the methylene chloride exposure level for employees manufacturing 
active pharmaceutical ingredients?” From this question, the following hypotheses were 
developed: 
 
Null 1: Employee exposure to methylene chloride will be equal to or less than the OSHA PEL. 
R 1:      Employee exposure to methylene chloride will be greater than the OSHA PEL.  
 
Null 2: Employee exposure to methylene chloride will be equal to or less than the OSHA AL. 
R 2:      Employee exposure to methylene chloride will be greater than the OSHA AL. 
 
To reject or not reject the null hypotheses, exposure monitoring was conducted to 
determine the exposure level.  
The final portion of the industrial hygiene report includes a discussion of the findings, 
conclusions, and recommendations. If either null hypothesis 1 or null hypothesis 2 are rejected, 
medical surveillance is required in accordance with 29 CFR 1910.1052. Further if null 
hypothesis 1 is rejected, regulation of the work area and engineering controls, administrative 
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controls, or personal protective equipment such as full-faced, supplied-air respirators are 
required to reduce employee exposure below the PEL.  
3. Background  
Methylene chloride, a chlorinated hydrocarbon, is a colorless liquid with high vapor 
pressure and a sweet odor (Agency for Toxic Substances and Disease Registry (ATSDR), 2000). 
It is easily evaporated, but does not readily burn (ATSDR, 2000). Methylene chloride is not 
naturally occurring; rather it is made from methane gas or wood alcohol (ATSDR, 2000). The 
chemical and physical properties of methylene chloride are presented in Table I. 
Table I: Chemical/Physical Data 
 
Parameter Methylene Chloride Properties 
Molecular Weight 84.9 
Boiling Point 39.8°C (104°F) 
Specific Gravity (water = 1) 1.3 
Vapor Density (air = 1) 2.9 
Vapor Pressure at 20°C (68°F) 350 millimeters mercury (mm Hg)  
Solubility in Water (grams/100 grams water at 
20°C (68°F)) 1.32 
Appearance and Odor Colorless liquid, chloroform-like odor 
(NIOSH, 2011 and ECSA, 2007) 
3.1. Toxicology 
The primary route of exposure to methylene chloride, a volatile organic compound, is 
through inhalation. As methylene chlorine is inhaled, over seventy percent is absorbed by the 
bloodstream and reaches a steady state in the blood within one to two hours of continuous 
exposure (Klaasen, 2008 and ATSDR, 2000). In the bloodstream, methylene chloride is 
distributed throughout the body with most of it going to the liver, kidney, brain, lungs and fatty 
tissue (ATSDR, 2000). Of the absorbed dose, less than five percent is exhaled as unchanged 
methylene chloride, while 25 to 34 percent is exhaled as carbon monoxide, an end metabolite of 
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methylene chloride (Klaasen, 2008). A small amount of methylene chloride leaves the body in 
urine (ATSDR, 2000). Methylene chloride is quickly eliminated from the body and was not 
shown to accumulate over a five day exposure regimen (Klaasen, 2008). 
A small amount of methylene chloride can be absorbed by the skin; however, when 
trapped against the skin by clothing or gloves, skin absorption can be greater and result in 
potential chemical burns (ATSDR, 2000).  
Absorption of methylene chloride through dermal exposure is relatively slow in 
comparison to inhalation. In scenarios where employees are wearing supplied-air, full face 
respirators and the skin is not protected (i.e., the employees are not wearing gloves), a sufficient 
amount of methylene chloride may be absorbed through the skin over an 8-hour work period to 
result in an internal concentration which would exceed that of employees exposed to methylene 
chloride by inhalation of 25 ppm for eight hours (OSHA, 2012). Employees at risk of hand 
contact with methylene chloride must wear impermeable gloves to prevent this route of exposure 
(OSHA, 2012). 
Methylene chloride is believed to be metabolized via three pathways as illustrated in 
Figure 5 (EPA, 2011). 
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Figure 5: Proposed pathways for methylene chloride metabolism 
 
1 – Mixed function oxidase pathway 
2 – Glutathione transferase pathway 
3 – Nucleophile pathway 
 
One of the pathways involves cytochrome P450 2E1 (CYP2E1)-catalyzed oxidation of 
methylene chloride to carbon monoxide via the reactive intermediate formyl chloride and is 
referred to as the mixed function oxidase (MFO) pathway (see Figure 5) (Klaasen, 2008 and 
ATSDR, 2000). This pathway is a high-affinity, low-capacity pathway and is the main pathway 
of methylene chloride metabolism for occupational exposure (Klaasen, 2008). It is suggested that 
this is the preferred pathway for the metabolism of inhaled methylene chloride (ATSDR, 2000). 
3 2
4 
1 
(a.k.a. Methylene Chloride) 
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As shown in Figure 5, the second pathway (i.e., the glutathione transferase pathway) is a 
glutathione (GSH)-mediated pathway involving the theta-class glutathione transferase (GST), 
GSTT1-1 (Klaasen, 2008 and ATSDR, 2000). The conjugation of GSH and methylene chloride 
results in the formation of reactive intermediates (i.e., S-(chloromethyl)glutathione and 
formaldehyde) which are eventually metabolized to carbon dioxide. The GST pathway is a low-
affinity, high-capacity pathway which is operative at high exposure levels (Klaasen, 2008). 
The suggested third pathway includes the formation of carbon dioxide via the MFO 
pathway due to the reaction of intermediate, proposed to be formyl chloride, with a nucleophile, 
such as glutathione (GSH), prior to the elimination of the chlorine ion (Klaasen, 2008 and 
ATSDR, 2000).  
3.2. Exposure Standards 
The OSHA regulation 29 CFR 1910.1052 establishes an AL of 12.5 ppm as an 8-hour 
time-weighted average (TWA) and a PEL of 25 ppm as an 8-hour TWA (OSHA, 2012). OSHA 
has also established a short-term exposure limit (STEL) of 125 ppm as measured over a fifteen 
minute exposure period (OSHA, 2012).  
In accordance with the regulatory standard, the employer must establish regulated areas 
(i.e., restricted area that is demarcated) when the PEL or the STEL are expected to be exceeded. 
In addition, when the PEL or STEL may be exceeded, the employer must provide respiratory 
protection. Only full face, supplied-air respirators are acceptable for methylene chloride 
exposure. Medical surveillance is required when employees are exposed at or above the AL for 
30 or more days per year or exceedances of the PEL or STEL for ten or more days per year. In 
addition, medical surveillance is also required if an employee is at risk from cardiac disease or 
other methylene chloride-related health condition. 
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When feasible, the employer must institute and maintain engineering controls and work 
practices to reduce employee exposure to below the PEL and STEL. Respiratory protection is 
then used to supplement engineering controls and work practices after the lowest level of 
exposure is achieved. 
The National Institute of Occupational Safety and Health (NIOSH) has not established a 
recommended exposure limit (REL) as measured for up to a 10-hour exposure period during a 
40-hour work week for methylene chloride (NIOSH, 2011). NIOSH identifies methylene 
chloride as a potential carcinogen and, therefore, recommends a “no exposure detectable levels 
for proven carcinogenic substances”. NIOSH intends to provide a REL based on human and/or 
animal data (NIOSH, 2011). NIOSH has identified an immediately dangerous to life and health 
(IDLH) level of 2,300 ppm (NIOSH, 2011). If the IDLH level is reached, the work area should 
be immediately evacuated.  
The American Conference of Governmental Industrial Hygienists (ACGIH) has 
established a threshold limit value (TLV) for methylene chloride of 50 ppm as measured over an 
8-hour period during a 40-hour work week.  
The German Commission for the Investigation of Health Hazards of Chemical 
Compounds in the Work Area (MAK Commission) has classified methylene chloride as a 
Category 3A carcinogen (i.e., a suspected carcinogen for which additional data is needed for 
further classification). (Greim, 2001). The MAK occupational exposure limit (OEL) is 100 ppm 
as measured over an 8-hour TWA (ECSA, 2007).  
The Netherland, the United Kingdom and Switzerland have established an 8-hour TWA 
OEL for methylene chloride of 100 ppm (ECSA, 2007). Sweden and France have also 
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established 8-hour TWA OELs for methylene chloride of 35 ppm and 50 ppm, respectively 
(ECSA, 2007).  
3.3. Site Evaluated 
The process evaluated is detailed in section 1.1 Process Description. The work activities 
are restricted to one room of the manufacturer’s facility. Employees return to their office while 
waiting for the reaction to take place or the solution in the reactor to separate.  
4. Effects of Exposure 
4.1. Target Organs  
Methylene chloride is considered a potential human carcinogen and is a confirmed 
carcinogen in rodents (Klaasen, 2008 and OSHA, 1997). Studies to date show little evidence of 
methylene chloride carcinogenicity in humans (Klaasen, 2008). OSHA concluded that a positive 
association between human exposure to methylene chloride and cancer incidence exists, but that 
the dose response relationship is not clear (OSHA, 1997) Additional research may clarify if 
methylene chloride is a human carcinogen.  
Other toxic effects of methylene chloride exposure include effects to the central nervous 
system, cardiac toxicity, hepatic toxicity, and reproductive toxicity (OSHA, 1997). 
Relatively mild, but reversible central nervous system depression is seen in humans when 
inhaled at low levels including levels as low as 200 ppm (OSHA, 1997).  Depression of the 
central nervous system as a result of methylene chloride exposure is characterized by tiredness 
and a decrease in attentiveness (OSHA, 1997). It has been suggested that repeated exposure to 
high levels of methylene chloride could result in irreversible central nervous system depression, 
however, a review of the studies by OSHA concluded that the results of these studies is not 
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supported (OSHA, 1997). Monitoring of future research by OSHA will continue due to concern 
about potential central nervous system effects at low levels (OSHA, 1997).  
Cardiac health effects are anticipated due to exposure to methylene chloride, or more 
specifically, the metabolite, carbon monoxide (OSHA, 1997). Carbon monoxide competes with 
oxygen and binds to hemoglobin producing carboxyhemoglobin (COHb) (OSHA, 1997). The 
reduction in oxygen delivery to tissues can result in myocardial infarction (OSHA, 1997). 
Animal studies have shown no evidence of direct toxic effects on cardiac tissue as the result of 
methylene chloride exposure (OSHA, 1997). In human studies, methylene chloride exposure 
resulted in increased blood COHb (OSHA, 1997). Human baseline levels of COHb are typically 
less than 1% (OSHA, 1997). Measurements of COHb of 24% and 30% were reported by one 
human study, but were believed to only occur at high levels of exposure to methylene chloride 
(i.e., greater than 500 ppm) (OSHA, 1997). OSHA, while concerned about the metabolism of 
methylene chloride to carbon monoxide, has determined that the risk for cardiac health effects is 
low (OSHA, 1997). OSHA will continue evaluate new research on this health effect (OSHA, 
1997).  
It is suspected that methylene chloride could be toxic to the liver as are other chlorinated 
hydrocarbons (e.g., carbon tetrachloride and chloroform) (OSHA, 1997). Mild liver effects (i.e., 
mild inflammatory response) were noted in rats and mice exposed to methylene chloride (OSHA, 
1997). In studies evaluating the chronic exposure of rats, mice and hamsters to methylene 
chloride, increased fatty liver, cytoplasic vacuolization and increased number of multinucleated 
hepatocytes were noted hepatic effects. OSHA’s review of these animal studies concluded that 
rodent livers are sensitive to chronic effects, but not acute effects of methylene chloride exposure 
(OSHA, 1997). Human studies provided mixed results. A study of acetate fiber production plant 
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workers was suggestive of a hepatotoxic response (i.e., increases in serum bilirubin and alanine 
aminotransferase) (OSHA, 1997). Hepatotoxic effects (i.e., liver function and enlarged liver) 
were also suggested of floor tile setters which were chronically exposed to methylene chloride at 
concentrations between 400 and 5,300 ppm. Case studies were not conclusive that methylene 
chloride was the causative agent of alteration of liver enzymes or hepatitis (OSHA). As a result 
of the review of studies in animals and humans and case reports, OSHA concluded that human 
heptotoxicity is not likely (OSHA, 1997).   
Animal studies have shown the fetus is sensitive to the methylene chloride metabolite, 
carbon monoxide producing central nervous system damage or reduced fetal growth. Limited 
data is available regarding teratogenicity effects in humans (OSHA, 1997). Carbon monoxide, a 
metabolite of methylene chloride, which reduces the amount of oxygen available to tissues, has 
been shown to have resulted in fetal or infant death (OSHA, 1997). OSHA concluded that it is 
aware of the reproductive effects of carbon monoxide and, therefore, there is still concern about 
the potential for methylene chloride teratogenicity. OSHA will continue to monitor research as it 
becomes available (OSHA, 1997).   
Ultimately, the exposure limits established by OSHA are based on carcinogenic and 
central nervous system effects (OSHA, 1997).  
4.2. Occupational Exposure Review 
No studies specific to methylene chloride exposure during the manufacture of active 
pharmaceutical ingredients were found with the exception of one which studied the risk for 
spontaneous abortion for females working in the pharmaceutical industry (Taskinen, 1986). The 
study supported there is increased risk of harmful effects on the pregnancy of female 
pharmaceutical workers using methylene chloride (Taskinen, 1986). Other factors (e.g., use of 
14 
four or more other solvents and heavy lifting) also increased the risk for spontaneous abortion 
(Taskinen, 1986). The study did not document exposure levels or other potential risk factors. 
This study was included in the human studies reviewed by OSHA for reproductive toxicity. 
OSHA concluded more research is necessary to evaluate the effects of methylene chloride 
exposure on potential pregnancy outcome (OSHA, 1997). 
A study of the effects of occupational exposure to methylene chloride and the subsequent 
production of COHb through metabolism in cellulose diacetate and triacetate fiber production 
workers in Rock Hill, South Carolina suggested no excess mortality was observed for ischemic 
heart disease (OSHA, 1997). NIOSH suggested that the study did not follow appropriate 
analytical techniques and additional studies are needed to evaluate the cardiac disease risks 
associated with methylene chloride exposure (OSHA, 1997). In an update to this study, 
bilary/liver cancer mortality was considered. While observed, it was not considered significantly 
significant (OSHA, 1997).  
A study of cellulose diacetate and triacetate fiber production workers in Cumberland, 
Maryland evaluated the relationship between exposure to methylene chloride and bilary/liver 
cancer (OSHA, 1997). In this study, incidents of bilary/liver cancer were observed, but no 
statistically significant elevated incidence was found (OSHA, 1997). Statistically significant 
mortality was observed from prostate, uterine and cervical cancers and is considered to be 
suggestive, but not conclusive evidence of the human carcinogenic effect (OSHA, 1997).  
Studies including a proportional mortality study and a retrospective mortality cohort 
study of film production workers exposed to methylene chloride were conducted (OSHA, 1997). 
No statistical significance was noted for these workers for ischemic heart disease or liver cancer 
in the proportional mortality study (OSHA, 1997). The cohort mortality study did identify 
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differences when compared with an external population, but it was not significantly significant 
(OSHA, 1997).  
An epidemiological study of employees exposed to methylene chloride during the 
manufacture of paint or varnish did identify cancers of the digestive organs, including the 
pancreas and peritoneum, but these were not considered to be statistically significant (OSHA, 
1997).  
A case-control study for astrocytic brain cancer among workers exposed to methylene 
chloride while producing or repairing electronic equipment suggests an association between 
methylene chloride exposure and brain cancer (OSHA, 1997). This study specifically looked at 
the potential association between brain cancer and exposure to chlorinated aliphatic 
hydrocarbons including methylene chloride. Duration of employment for occupations or 
industries with exposure, a cumulative exposure score and “average” intensity of exposure were 
used as surrogate measures of exposure (OSHA, 1997). Exposure intensity categories were used 
for calculating odds ratios. As the probability of exposure to organic solvents, particularly 
methylene chloride, increased so did the risk for brain cancer (OSHA, 1997).  
5. Research Design and Methods 
The results of exposure sampling data were evaluated and compared to the OSHA PEL 
and AL. OSHA requires exposure monitoring to be accurate at the 95% confidence interval to 
within plus or minus 25% at concentrations above 25 ppm and within plus or minus 35% at 
concentrations between 12.5 and 25 ppm.  
For the manufacturer of active pharmaceutical ingredients, exposure to methylene 
chloride occurs during the transfer of the methylene chloride from pails into the reactor. After the 
liquid is contained within the reactor vessel, the process operates in a closed system during 
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which there is no exposure. Exposure may also occur when fractions are then extracted from the 
reactor by draining the contents from the bottom of the reactor.  
Established OSHA methylene chloride sampling methods (i.e., OSHA 80 and OSHA 59) 
are established for 5-minute sampling periods (OSHA, no date provided). Due to the Class I 
Division 2 requirements of the room, passive badges were selected over utilizing charcoal tubes 
with air sampling pumps. Exposure monitoring was conducted utilizing 3M Organic Vapor 
Monitors Badge 3520 (3520 Monitor). Sampling for methylene chloride using the 3520 Monitor 
is shown to meet the OSHA accuracy requirements for methylene chloride (OSHA, 1997).  
The badges contain a charcoal adsorbent pad and operate on the principle of diffusion. 
Temperature affects will not be significant between 50 and 104 degrees Fahrenheit (°F). The 
temperature of the building is controlled to be within this range. Relative humidity levels can 
affect sampler accuracy. High relative humidity during sampling may result in decreased 
recovery (3M, 1997). Uptake of methylene chloride can be affected at relative humidity rates 
exceeding 50% at which the capacity may be significantly reduced (3M, 1997). Relative 
humidity was measured and recorded at the time exposure monitoring was initiated. All relative 
humidity readings were below 50%.  
Occupational exposure sampling was conducted during three client campaigns in 
February and March 2014. The campaigns follow similar work procedures and each included 
approximately 100 kilograms (i.e., between 80 and 100 kilograms) of methylene chloride. Each 
of the campaigns followed the same process detailed in section 1.1 Process Description. The 
difference between the campaigns would have included the proprietary active ingredient and 
slight variations in the volume of chemicals used.  
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The employee anticipated to have the greatest exposure to methylene chloride (i.e., the 
employee that was responsible for transferring methylene chloride from pails into the reactor) 
was selected to wear the 3520 Monitor for the initial sampling event. After the initial exposure 
monitoring indicated the AL was exceeded, both employees involved with the process wore 
monitoring badges in subsequent sampling events. Manufacturing events do not occur on a 
regular schedule. Rather the events are sporadic, occurring with client demand. Two sampling 
events occurred in February 2014 and one sampling event occurred in March 2014.  
The badges were distributed at the beginning of the monitoring period. The badge is 
clipped to the laboratory coat collar to take a personal breathing zone air sample and be 
representative of the employee’s exposure. The badges were worn by employees for the full 
duration of the manufacturing process. Upon completion of the monitoring, the plastic ring and 
white film were removed from the monitor and caps secured to each portion of the monitor in 
preparation for shipment to the analytical lab. 
After observing work activities during the initial campaign, a 3520 Monitor was issued to 
two employees performing these activities during the second and third campaigns. This allowed 
for the exposure of the employee transferring the liquid as well as a support employee that would 
transport closed containers. These are the only two employees within the room during these 
procedures.  
The samples were analyzed by ALS Environmental, a laboratory accredited by the 
American Industrial Hygiene Association (AIHA) as an industrial hygiene laboratory. 
As detailed in Section 1.1 Process Description, during work activities both employees 
wear supplied-air, full-faced respirators, laboratory coats and chemical-compatible gloves. In 
addition, localized ventilation (i.e., extraction arm) is positioned near the opening of the reactor. 
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6. Results 
The occupational exposure sampling was conducted in accordance with a method that 
will provide an initial exposure determination in accordance with 29 CFR 1910.1052. 
Conducting 8-hour methylene chloride sampling with the 3M 3520 badge meets the OSHA 
accuracy requirements (3M, 1997).  
An 8-hour work shift is composed of 480 minutes. Exposure during the time period not 
monitored would have occurred outside the laboratory as office time and would not have had any 
methylene chloride exposure. The typical work shift is 8-hours, but may vary with the time 
needed for the solution to separate. Employees would wear the badges for the duration of their 
work in the laboratory. The employees continued to wear the badges during breaks or office time 
(i.e., the badges were not left in the laboratory). In the event the employee’s work in the 
laboratory was completed for the day and they would not be returning, the badge was collected. 
To calculate the methylene chloride exposure for an 8-hour time-weighted average (TWA), 
equation (1) shown below was utilized.  
TWA  = 
 (Concentration1 * Time1) + (Concentration2 * Time2) 
(1) 
Time  
 
The calculated analytical results and calculated 8-hour TWA are presented below in 
Table II.  
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Table II: Analytical Results and 8-Hour TWA 
 
Sample Campaign Location 
Relative 
Humidity 
(%) 
Exposure 
Time 
(minutes) 
Analytical 
Results 
(ppm) 
8-Hour 
TWA (ppm) 
NG5160 1 Employee 1 7.1 361 22 16.65 
NG5155 2 Employee 2 20.5 568 15 17.75 
NW6944 2 Employee 1 29.1 413 22 18.93 
NW7307 3 Employee 2 24.6 180 110 41.25 
NG6937 3 Employee 1 25.0 510 38 40.38 
NW7305 NA Blank NA NA ND ND 
NW7307 NA Blank NA NA ND ND 
NA = not applicable 
ND = non-detect 
 
The American Industrial Hygiene Association’s (AIHA’s) Industrial Hygiene Statistic 
(IHSTAT) tool to perform statistical calculations of industrial hygiene data was utilized to 
interpret these results (AIHA, 1998). The spreadsheet is presented in Appendix C.  
The W-test value indicates the rejection of the normal distribution and the lognormal 
distribution is not rejected.  
The Logprobability Plot and Least Squares Best Fit Line indicates an excellent fit as the 
data (i.e., the white circles) are near the line. The Linear Probability Plot and Least Squares Best 
Fit Line does not fit as indicated by the data point not being visible on the graph.  
Based on this information, the data set is lognormally distributed. Therefore, the 
lognormal statistics are used to interpret the results.  
The arithmetic mean is estimated to be 26.91 ppm. The Upper Confidence Limit (UCL), 
indicated by the cell labeled UCL1, 95% %>OEL, indicates that the PEL is exceeded 76.33% of 
the time. Based on this analysis, the exposure level is unacceptable when compared with the 
established PEL.  
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7. Discussion 
The OSHA regulation 29 CFR 1910.1052 establishes an AL of 12.5 ppm as an 8-hour 
TWA and a PEL of 25 ppm as an 8-hour TWA.  
Null hypothesis 1, employee exposure to methylene chloride will be equal to or less than 
the OSHA PEL, is rejected.  
Null hypothesis 2, employee exposure to methylene chloride will be equal to or less than 
the OSHA AL, is rejected.  
A short-term exposure limit (STEL), established by OSHA to be 125 ppm for methylene 
chloride as determined over a sampling period of 15 minutes, was not conducted as part of this 
assessment. It is recommended that additional monitoring be conducted to determine the short-
term exposure of employees for comparison to the STEL.  
As the exposure levels exceed the AL and the PEL, the continued monitoring should 
occur at the frequency shown in Table 1 of the OSHA standard (OSHA, 2012) (see Table III). 
This table indicates sampling should e conducted for the PEL and the STEL every three months.  
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Table IIII: Initial Determination Exposure Scenarios and Their Associated Monitoring 
Frequencies 
 
Exposure scenario Required monitoring activity 
Below the action level and at or below the 
STEL. 
No 8-hour TWA or STEL monitoring required. 
Below the action level and above the STEL No 8-hour TWA monitoring required; monitor STEL exposures every three months. 
At or above the action level, at or below the 
TWA, and at or below the STEL. 
Monitor 8-hour TWA exposures every six months. 
At or above the action level, at or below the 
TWA, and above the STEL. 
Monitor 8-hour TWA exposures every six months and monitor STEL exposures every 
three months. 
Above the TWA and at or below the STEL Monitor 8-hour TWA exposures every three months. In addition, without regard to the 
last sentence of the note to paragraph (d)(3), the following employers must monitor 
STEL exposures every three months until either the date by which they must achieve 
the 8-hour TWA PEL under paragraph (n) of this section or the date by which they in 
fact achieve the 8-hour TWA PEL, whichever comes first: employers engaged in 
polyurethane foam manufacturing; foam fabrication; furniture refinishing; general 
aviation aircraft stripping; product formulation; use of MC-based adhesives for boat 
building and repair, recreational vehicle manufacture, van conversion, or upholstery; 
and use of MC in construction work for restoration and preservation of buildings, 
painting and paint removal, cabinet making, or floor refinishing and resurfacing. 
Above the TWA and above the STEL Monitor 8-hour TWA exposures and STEL exposures every three months. 
 (OSHA, 2012) 
 
While this project been adequate to reject or not reject the hypotheses, additional 
monitoring to assess short-term exposure is necessary.  
8. Conclusions 
Methylene chloride is a suspect human carcinogen and may result in central nervous 
system effects, cardiac toxicity, hepatic toxicity, and reproductive toxicity. Due to these risks, it 
is important to evaluate exposure levels. Based on the results, it has been determined that 
employees are exposed to methylene chloride above the OSHA PEL and AL.  
The results of the occupational exposure sampling indicate employees are exposed to 
levels of methylene chloride above the PEL and the AL. The regulatory standard requires 
respiratory protection and regulation of the work area when employees are exposure above the 
PEL. Medical monitoring is required for employees exposed to levels above the AL or the PEL.  
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Recommendations to reduce exposure include identifying a substitute solvent that is less 
hazardous. Substitution is considered the ideal method for reducing employee exposure to 
methylene chloride.  
To control exposure through an engineering control, an evaluation of the current 
localized ventilation system would be valuable in determining existing capabilities for reducing 
exposure to methylene chloride vapors. If this is not possible with the current ventilation system, 
other ventilation options could be explored.  
An engineering control to reduce exposure during methylene chloride transfer from pails 
to the reactor may be achieved by applying nitrogen pressure to the bucket to force methylene 
chloride from one container to the reactor vessel from a remote location.  
Reduction of exposure during transfer from the bottom of the reactor to collection pails 
may be achieved by attaching a hose to the bottom of the reactor and channeling discharge into a 
closed top container.  
The implementation of any of these controls would necessitate additional exposure 
monitoring to evaluate the effectiveness. 
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 Appendix A:  Laboratory Results 
 
06-Mar-2014
Nitto Denko Avecia
Janet Rullman
Dear Janet,
Re: NOA Work Order: 1402645
Fax: (508) 482-7510
Tel: (513) 771-3667
8560 Reading Road
Cincinnati, OH  45215
ALS Environmental received 4 samples on 27-Feb-2014 01:30 PM for the analyses presented in the 
following report.
Project Manager
Chris Gibson
 Chris Gibson
Electronically approved by: Rob Nieman
The analytical data provided relates directly to the samples received by ALS Environmental and for only 
the analyses requested. 
QC sample results for this data met laboratory specifications.  Any exceptions are noted in the Case 
Narrative, or noted with qualifiers in the report or QC batch information.   Should this laboratory report 
need to be reproduced, it should be reproduced in full unless written approval has been obtained from 
ALS Laboratory Group. Samples will be disposed in 30 days unless storage arrangements are made.
The total number of pages in this report is 7.
If you have any questions regarding this report, please feel free to contact me.
Sincerely,
ADDRESS 4388 Glendale Milford Rd  Cincinnati, Ohio 45242- | PHONE (513) 733-5336 | FAX (513) 733-5347
ALS GROUP USA, CORP.  Part of the ALS Group  An ALS Limited Company
Date: 06-Mar-14ALS Environmental
Project: NOA
Client: Nitto Denko Avecia
Work Order: 1402645
Work Order Sample Summary
Lab Samp ID Client Sample ID Collection DateTag Number Date ReceivedMatrix Hold
1402645-01 NG5160 Air 2/27/2014 2/27/2014 13:30
1402645-02 NG5155 Air 2/27/2014 2/27/2014 13:30
1402645-03 NW6944 Air 2/27/2014 2/27/2014 13:30
1402645-04 NW7305 Air 2/27/2014 2/27/2014 13:30
SS Page 1 of  1
Date: 06-Mar-14ALS Environmental
Project: NOA
Client: Nitto Denko Avecia
Work Order: 1402645
Case Narrative
The sample condition upon receipt was acceptable except where noted.
Results relate only to the items tested and are not blank corrected unless indicated.
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Project: NOA
Client: Nitto Denko Avecia Work Order: 1402645
ALS Environmental Date: 06-Mar-14
Analytical Results
Client Sample ID: NG5160
Lab ID: 1402645-01A Collection Date: 2/27/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/6/2014
Time (Min): 361
Methylene Chloride 10890 22
Client Sample ID: NG5155
Lab ID: 1402645-02A Collection Date: 2/27/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/6/2014
Time (Min): 568
Methylene Chloride 10970 15
Client Sample ID: NW6944
Lab ID: 1402645-03A Collection Date: 2/27/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/6/2014
Time (Min): 413
Methylene Chloride 101,000 22
Client Sample ID: NW7305
Lab ID: 1402645-04A Collection Date: 2/27/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/6/2014
Time (Min): 0
Methylene Chloride 10ND NA
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Note:
Date: 06-Mar-14ALS Environmental
Project: NOA
Client: Nitto Denko Avecia
Work Order: 1402645
QC BATCH REPORT
Batch ID: 21206 Instrument ID: GC4 Method: 3M
Qual
RPD 
Limit
Analysis Date: 3/6/2014
Prep Date:
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 775248
MBLK
Run ID: GC4_140306A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID: MBLK-21206-21206
Methylene Chloride 10ND
Qual
RPD 
Limit
Analysis Date: 3/6/2014
Prep Date:
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 775249
LCS
Run ID: GC4_140306A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID: LCS-21206-21206
00132.5Methylene Chloride 109  70-13010144.4
Qual
RPD 
Limit
Analysis Date: 3/6/2014
Prep Date:
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 775254
LCSD
Run ID: GC4_140306A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID: LCSD-21206-21206
144.40132.5Methylene Chloride 122  70-130 2010 11.4161.9
The following samples were analyzed in this batch: 1402645-01A 1402645-02A 1402645-03A
1402645-04A
QC Page: 1 of  1
Note:   See Qualifiers Page for a list of Qualifiers and their explanation.
ALS Environmental Date: 06-Mar-14
QUALIFIERS, 
ACRONYMS, UNITSProject: NOA
Client: Nitto Denko Avecia
WorkOrder: 1402645
Units Reported             Description 
Qualifier             Description
Acronym             Description 
µg/sample
Value exceeds Regulatory Limit*
Not accrediteda
Analyte detected in the associated Method Blank above the Reporting LimitB
Value above quantitation rangeE
Analyzed outside of Holding TimeH
Analyte detected below quantitation limitJ
Not offered for accreditationn
Not Detected at the Reporting LimitND
Sample amount is > 4 times amount spikedO
Dual Column results percent difference > 40%P
RPD above laboratory control limitR
Spike Recovery outside laboratory control limitsS
Analyzed but not detected above the MDLU
Method DuplicateDUP
EPA MethodE
Laboratory Control SampleLCS
Laboratory Control Sample DuplicateLCSD
Method BlankMBLK
Method Detection LimitMDL
Method Quantitation LimitMQL
Matrix SpikeMS
Matrix Spike DuplicateMSD
Post Digestion SpikePDS
Practical Quantitaion LimitPQL
Sample Detection LimitSDL
SW-846 MethodSW
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ALS Environmental
Sample Receipt Checklist
Client Name: NITTODENKOAVECIA-CINCINN
Work Order: 1402645
Date/Time Received: 27-Feb-14 13:30
Received by: RDN
Checklist completed by:
eSignature Date
Reviewed by:
DateeSignature
Matrices:
Carrier name: Client
Shipping container/cooler in good condition? Yes No Not Present
Custody seals intact on shipping container/cooler? Yes No Not Present
Custody seals intact on sample bottles? Yes No Not Present
Chain of custody present? Yes No
Chain of custody signed when relinquished and received? Yes No
Chain of custody agrees with sample labels? Yes No
Samples in proper container/bottle? Yes No
Sample containers intact? Yes No
Sufficient sample volume for indicated test? Yes No
All samples received within holding time? Yes No
Container/Temp Blank temperature in compliance? Yes No
Yes No No VOA vials submittedWater - VOA vials have zero headspace?
Water - pH acceptable upon receipt? Yes No N/A
Temperature(s)/Thermometer(s):
Login Notes:
Cooler(s)/Kit(s):
27-Feb-14 04-Mar-14 Shannon Darling  Rob Nieman
pH adjusted? Yes No N/A
pH adjusted by:  
CorrectiveAction:
Comments:
Client Contacted: Date Contacted: Person Contacted:
Contacted By: Regarding:
SRC Page 1 of  1

14-Mar-2014
Nitto Denko Avecia
Janet Rullman
Dear Janet,
Re: DCM/MC; NDA Work Order: 1403271
Fax: (508) 482-7510
Tel: (513) 301-8058
8560 Reading Road
Cincinnati, OH  45215
ALS Environmental received 3 samples on 11-Mar-2014 12:32 PM for the analyses presented in the 
following report.
Project Manager
Chris Gibson
 Chris Gibson
Electronically approved by: Chris Gibson
The analytical data provided relates directly to the samples received by ALS Environmental and for only 
the analyses requested. 
QC sample results for this data met laboratory specifications.  Any exceptions are noted in the Case 
Narrative, or noted with qualifiers in the report or QC batch information.   Should this laboratory report 
need to be reproduced, it should be reproduced in full unless written approval has been obtained from 
ALS Laboratory Group. Samples will be disposed in 30 days unless storage arrangements are made.
The total number of pages in this report is 6.
If you have any questions regarding this report, please feel free to contact me.
Sincerely,
ADDRESS 4388 Glendale Milford Rd  Cincinnati, Ohio 45242- | PHONE (513) 733-5336 | FAX (513) 733-5347
ALS GROUP USA, CORP.  Part of the ALS Group  An ALS Limited Company
Date: 14-Mar-14ALS Environmental
Project: DCM/MC; NDA
Client: Nitto Denko Avecia
Work Order: 1403271
Work Order Sample Summary
Lab Samp ID Client Sample ID Collection DateTag Number Date ReceivedMatrix Hold
1403271-01 NW 6937 Air 3/4/2014 3/11/2014 12:32
1403271-02 NW 7306 Air 3/4/2014 3/11/2014 12:32
1403271-03 NW 7307 Air 3/4/2014 3/11/2014 12:32
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Project: DCM/MC; NDA
Client: Nitto Denko Avecia Work Order: 1403271
ALS Environmental Date: 14-Mar-14
Analytical Results
Client Sample ID: NW 6937
Lab ID: 1403271-01A Collection Date: 3/4/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/12/2014
Time (Min): 510
Methylene Chloride 102,200 38
Client Sample ID: NW 7306
Lab ID: 1403271-02A Collection Date: 3/4/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/12/2014
Time (Min): 180
Methylene Chloride 102,300 110
Client Sample ID: NW 7307
Lab ID: 1403271-03A Collection Date: 3/4/2014
Matrix: AIR
Analyses
ANALYTE(S) BY 3M OVM ANALYSIS GUIDE 3M Analyst: TSAMethod:
µg/sample µg/sample ppm
Reporting LimitDate Analyzed: 3/12/2014
Time (Min): 0
Methylene Chloride 10ND NA
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Note:
Date: 14-Mar-14ALS Environmental
Project: DCM/MC; NDA
Client: Nitto Denko Avecia
Work Order: 1403271
QC BATCH REPORT
Batch ID: 21358 Instrument ID GC4 Method: 3M
Qual
RPD 
Limit
Analysis Date: 3/12/2014
Prep Date: 3/12/2014
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 780720
MBLK
Run ID: GC4_140312A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID MBLK-21358-21358
Methylene Chloride 10ND
Qual
RPD 
Limit
Analysis Date: 3/12/2014
Prep Date: 3/12/2014
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 780721
LCS
Run ID: GC4_140312A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID LCS-21358-21358
00132.5Methylene Chloride 102  70-13010134.6
Qual
RPD 
Limit
Analysis Date: 3/12/2014
Prep Date: 3/12/2014
Analyte Result %REC %RPD
Units: µg/sample
PQL
Client ID: SeqNo: 780725
LCSD
Run ID: GC4_140312A
SPK Val
SPK Ref 
Value
RPD Ref 
Value
Control 
Limit
DF: 1
Sample ID LCSD-21358-21358
134.60132.5Methylene Chloride 98.7  70-130 2010 2.86130.8
The following samples were analyzed in this batch: 1403271-01A 1403271-02A 1403271-03A
QC Page: 1 of  1
Note:   See Qualifiers Page for a list of Qualifiers and their explanation.
ALS Environmental Date: 14-Mar-14
QUALIFIERS, 
ACRONYMS, UNITS
Project: DCM/MC; NDA
Client: Nitto Denko Avecia
WorkOrder: 1403271
Units Reported             Description 
Qualifier             Description
Acronym             Description 
µg/sample
Value exceeds Regulatory Limit*
Not accrediteda
Analyte detected in the associated Method Blank above the Reporting LimitB
Value above quantitation rangeE
Analyzed outside of Holding TimeH
Analyte detected below quantitation limitJ
Not offered for accreditationn
Not Detected at the Reporting LimitND
Sample amount is > 4 times amount spikedO
Dual Column results percent difference > 40%P
RPD above laboratory control limitR
Spike Recovery outside laboratory control limitsS
Analyzed but not detected above the MDLU
Method DuplicateDUP
EPA MethodE
Laboratory Control SampleLCS
Laboratory Control Sample DuplicateLCSD
Method BlankMBLK
Method Detection LimitMDL
Method Quantitation LimitMQL
Matrix SpikeMS
Matrix Spike DuplicateMSD
Post Digestion SpikePDS
Practical Quantitaion LimitPQL
Sample Detection LimitSDL
SW-846 MethodSW
QF Page 1 of 1
ALS Environmental
Sample Receipt Checklist
Client Name: NITTODENKOAVECIA-CINCINNA
Work Order: 1403271
Date/Time Received: 11-Mar-14 12:32
Received by: JNW
Checklist completed by
eSignature Date
Reviewed by:
DateeSignature
Matrices:
Carrier name: Client
Shipping container/cooler in good condition? Yes No Not Present
Custody seals intact on shipping container/cooler? Yes No Not Present
Custody seals intact on sample bottles? Yes No Not Present
Chain of custody present? Yes No
Chain of custody signed when relinquished and received? Yes No
Chain of custody agrees with sample labels? Yes No
Samples in proper container/bottle? Yes No
Sample containers intact? Yes No
Sufficient sample volume for indicated test? Yes No
All samples received within holding time? Yes No
Container/Temp Blank temperature in compliance? Yes No
Yes No No VOA vials submittedWater - VOA vials have zero headspace?
Water - pH acceptable upon receipt? Yes No N/A
Temperature(s)/Thermometer(s):
Login Notes:
Cooler(s)/Kit(s):
11-Mar-14 Rob Nieman  
pH adjusted? Yes No N/A
pH adjusted by:  
CorrectiveAction:
Comments:
Client Contacted: Date Contacted: Person Contacted:
Contacted By: Regarding:
SRC Page 1 of  1

 Appendix B: Calculations 
 
 
  
 Using equation (1) and the laboratory analytical results, the 8-hour TWA for each sample 
was calculated. 
TWA(Campaign 1 – Employee 1)  =  
 (22 ppm* 361 minutes) + (0 ppm * 119 minutes) 
= 16.55 ppm 
 
480 minutes  
 
TWA(Campaign 2 – Employee 2)  =  
 (15 ppm* 568 minutes) 
= 17.75 ppm 
 
480 minutes  
 
TWA(Campaign 2 – Employee 1)  =  
 (22 ppm* 413 minutes) + (0 ppm * 67 minutes) 
= 18.93 ppm 
 
480 minutes  
 
TWA(Campaign 3 – Employee 2)  =  
(110 ppm* 180 minutes) + (0 ppm * 300 minutes) 
= 41.25 ppm 
 
480 minutes  
 
TWA(Campaign 3 – Employee 1)  =  
(38 ppm* 510 minutes) 
= 40.38 ppm 
 
480 minutes  
 
 
 Appendix C: IHSTAT 
 
 
Conception: John R. Mulhausen, Ph.D., CIH
modified by Daniel Drolet, IRSST rev IHSTATv212 - Ihstats 6/10/2014 - 8:45 AM
Industrial Hygiene Statistics 
Sequential Data Plot
OEL
25
Sample 
data
16.65 Descriptive statistics
17.75 Number of samples (n) 5
18.93 Maximum (max) 41.25
41.25 Minimum (min) 16.65
40.38 Range 24.6
Mean 26.992
Median 18.930
Standard deviation (s) 12.648
Geometric mean 24.767
Geometric standard deviation 1.581
Percent above OEL 40.0%
Test for distribution fit
W-test of log-transformed data 0.764 Idealized Lognormal Distribution
Lognormal (α = 0.05) ? Yes
W-test of data 0.743
Normal (α = 0.05) ? No
Lognormal parametric statistics
Estimated Arithmetic Mean - AM est. 26.907
LCL1,95% - Land's "Exact" 19.079
UCL1,95% - Land's "Exact" 52.435
95th Percentile 52.635
UTL95%,95% 169.899
Percent above OEL 49.2%
LCL1,95% %>OEL 22.505
UCL1,95% %>OEL 76.327
Normal parametric statistics
Mean 26.992
LCL1,95% - t statistics 14.933
UCL1,95% - t statistics 39.051
95th Percentile - Z 47.798
UTL95%,95% 80.14
Percent above OEL 56.26
Linear Probability Plot and Least-Squares Best-Fit Line
Logprobability Plot and Least-Squares Best-Fit Line


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